Combined Esculentin-2CHa Fusion Protein-Coated Au Nanoparticles for Effective Against Non-Alcoholic Fatty Liver Disease in Mice Model
Overall, this study has demonstrated the promising potential of ESC-ABD-AuNPs as a novel treatment for NAFLD. This research suggests that ESC-ABD-AuNPs could be a significant advancement in drug delivery and liver disease treatment, particularly for combination therapies.
Authors
- Cheol Moon (ORCID: https://orcid.org/0000-0003-2342-0860)
- Reeju Amatya (ORCID: https://orcid.org/0000-0002-1724-6619)
- Amala Joseph
- Kyoung Ah Min (ORCID: https://orcid.org/0000-0002-0767-4927)
- Yassmine Benmokadem
- Gu Seob Roh (ORCID: https://orcid.org/0000-0003-4010-9628)
- Meong Cheol Shin (ORCID: https://orcid.org/0000-0001-8035-923X)
- Doyeon Kim (ORCID: https://orcid.org/0000-0003-0812-3905)
Institutions
- Inje University (KR)
- Gyeongsang National University (KR)
- Sunchon National University (KR)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/ijn.s497645
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- National Research Foundation
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea